• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-FDG PET上的最大标准化摄取值与磷酸化Akt和S6激酶表达之间的临床显著关联对预测肾细胞癌生物学特性的作用

Clinically significant association between the maximum standardized uptake value on 18F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer.

作者信息

Mizuno Tomoya, Kamai Takao, Abe Hideyuki, Sakamoto Setsu, Kitajima Kazuhiro, Nishihara Daisaku, Yuki Hideo, Kambara Tsunehito, Betsunoh Hironori, Yashi Masahiro, Fukabori Yoshitatsu, Kaji Yasushi, Yoshida Ken-Ichiro

机构信息

Department of Urology, Dokkyo Medical University, 880 Kitakobayashi Mibu, Tochigi, 321-0293, Japan,

出版信息

BMC Cancer. 2015;15:1097. doi: 10.1186/s12885-015-1097-0. Epub 2015 Mar 10.

DOI:10.1186/s12885-015-1097-0
PMID:25784113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4357069/
Abstract

BACKGROUND

The relationship between the clinicopathological features and molecular changes associated with standardized uptake value (SUV) determined by Positron emission tomography (PET) with [18F] fluorodeoxyglucose (18F-FDG PET) in human renal cell carcinoma (RCC) has not been elucidated. On the other hand, overactivation of the phosphatidylinositol 3'kinase (PI3K), serine/threonine kinase Akt, and mammalian target of rapamycin (mTOR) pathway has been detected in a variety of human cancers, including RCC. So far, little is known about the relationship between the SUV and these proteins in human RCC. Thus, it is important to study the relevance of SUV with clinicopathological features in human RCCs from a molecular point of view.

METHODS

Seventy-seven consecutive patients with RCC who underwent nephrectomy and pretreatment determination of the maximum SUV (SUVmax) by 18F-FDG PET were analyzed. We investigated the relationship between the SUVmax, phosphorylated-Akt (Ser-473) (pAkt(Ser-473)), phosphorylated-Akt (Thr-308) (pAkt(Thr-308), and phosphorylated-S6 ribosomal protein (Ser-235/236) (pS6) protein levels in the primary tumor and various clinicopathological features.

RESULTS

The average SUVmax of the primary tumor was 6.9 (1.5 to 40.3). A higher SUVmax was correlated with higher expression of pAkt(Ser-473), pAkt (Thr-308), and pS6 protein in the primary tumor. A higher SUVmax and increased expression of pAkt (Ser-473), pAkt (Thr-308), and pS6 of the primary tumor was associated with less tumor differentiation, a higher pT stage, regional lymph node involvement, microscopic vascular invasion, and distant metastasis, as well as with early relapse following radical nephrectomy in patients who had localized or locally advanced RCC without distant metastasis (cTanyNanyM0) and with shorter overall survival in all patients.

CONCLUSIONS

A higher SUVmax on 18F-FDG PET is associated with elevated tumor levels of pAkt and pS6 protein and with aggressive behavior and metastatic potential of RCC, as well as with early relapse following radical nephrectomy and shorter overall survival. These findings suggest that SUVmax may be useful for predicting the biological characteristics of RCC.

摘要

背景

正电子发射断层扫描(PET)联合[18F]氟脱氧葡萄糖(18F-FDG PET)测定的标准化摄取值(SUV)与人类肾细胞癌(RCC)临床病理特征及分子改变之间的关系尚未阐明。另一方面,在包括RCC在内的多种人类癌症中均检测到磷脂酰肌醇3'激酶(PI3K)、丝氨酸/苏氨酸激酶Akt和雷帕霉素靶蛋白(mTOR)通路的过度激活。到目前为止,关于人类RCC中SUV与这些蛋白之间的关系知之甚少。因此,从分子角度研究SUV与人类RCC临床病理特征的相关性具有重要意义。

方法

分析77例接受肾切除术并在术前通过18F-FDG PET测定最大SUV(SUVmax)的连续性RCC患者。我们研究了原发肿瘤中SUVmax、磷酸化Akt(Ser-473)(pAkt(Ser-473))、磷酸化Akt(Thr-308)(pAkt(Thr-308))和磷酸化S6核糖体蛋白(Ser-235/236)(pS6)蛋白水平与各种临床病理特征之间的关系。

结果

原发肿瘤的平均SUVmax为6.9(1.5至40.3)。较高的SUVmax与原发肿瘤中pAkt(Ser-473)、pAkt(Thr-308)和pS6蛋白的高表达相关。原发肿瘤较高的SUVmax以及pAkt(Ser-473)、pAkt(Thr-308)和pS6表达增加与肿瘤分化较差、较高的pT分期、区域淋巴结受累、微血管侵犯和远处转移相关,也与局限性或局部进展性且无远处转移(cTanyNanyM0)的患者根治性肾切除术后早期复发以及所有患者较短的总生存期相关。

结论

18F-FDG PET上较高的SUVmax与RCC肿瘤中pAkt和pS6蛋白水平升高、侵袭性行为和转移潜能相关,也与根治性肾切除术后早期复发和较短的总生存期相关。这些发现表明SUVmax可能有助于预测RCC的生物学特征。

相似文献

1
Clinically significant association between the maximum standardized uptake value on 18F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer.18F-FDG PET上的最大标准化摄取值与磷酸化Akt和S6激酶表达之间的临床显著关联对预测肾细胞癌生物学特性的作用
BMC Cancer. 2015;15:1097. doi: 10.1186/s12885-015-1097-0. Epub 2015 Mar 10.
2
Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report.18F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(18F-FDG-PET/CT)评估的最大标准化摄取值(SUVmax)对晚期肾细胞癌患者生存的影响:初步报告。
BMC Cancer. 2010 Dec 3;10:667. doi: 10.1186/1471-2407-10-667.
3
Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy.mTOR通路在肾细胞癌中的预后相关性:对分子靶向治疗患者选择的意义
Cancer. 2007 Jun 1;109(11):2257-67. doi: 10.1002/cncr.22677.
4
Comparison of 11C-4DST and 18F-FDG PET/CT imaging for advanced renal cell carcinoma: preliminary study.11C-4DST 和 18F-FDG PET/CT 成像在晚期肾细胞癌中的比较:初步研究。
Abdom Radiol (NY). 2016 Mar;41(3):521-30. doi: 10.1007/s00261-015-0601-y.
5
The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy.通过FDG PET/CT评估的肾细胞癌中葡萄糖蓄积加速表明对酪氨酸激酶抑制剂治疗产生了耐药性。
BMC Cancer. 2017 Jan 9;17(1):39. doi: 10.1186/s12885-016-3044-0.
6
Diagnostic performance and prognostic value of preoperative F-FDG PET/CT in renal cell carcinoma patients with venous tumor thrombus.术前 F-FDG PET/CT 对伴有静脉瘤栓的肾细胞癌患者的诊断性能和预后价值。
Cancer Imaging. 2022 Nov 26;22(1):65. doi: 10.1186/s40644-022-00502-1.
7
One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.使用氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)对依维莫司治疗的肾细胞癌进行的1个月评估可预测无进展生存期和总生存期。
Cancer Chemother Pharmacol. 2017 May;79(5):855-861. doi: 10.1007/s00280-017-3275-z. Epub 2017 Mar 22.
8
Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.对于乳腺癌,肿瘤大小和增殖标志物geminin而非Ki67的表达水平与正电子发射断层扫描中18F-脱氧葡萄糖水平的最大摄取显著相关。
PLoS One. 2017 Sep 8;12(9):e0184508. doi: 10.1371/journal.pone.0184508. eCollection 2017.
9
FDG PET/CT and CT Findings of Renal Cell Carcinoma With Sarcomatoid Differentiation.具有肉瘤样分化的肾细胞癌的 FDG PET/CT 和 CT 表现。
AJR Am J Roentgenol. 2020 Sep;215(3):645-651. doi: 10.2214/AJR.19.22467. Epub 2020 Jul 1.
10
Renal Masses Detected on FDG PET/CT in Patients With Lymphoma: Imaging Features Differentiating Primary Renal Cell Carcinomas From Renal Lymphomatous Involvement.淋巴瘤患者FDG PET/CT检查发现的肾脏肿块:鉴别原发性肾细胞癌与肾淋巴瘤累及的影像学特征
AJR Am J Roentgenol. 2017 Apr;208(4):849-853. doi: 10.2214/AJR.16.17133. Epub 2017 Jan 17.

引用本文的文献

1
F-FDG PET/CT for predicting inferior vena cava wall invasion in patients of renal cell carcinoma with the presence of inferior vena cava tumor thrombus.18F-FDG PET/CT 预测合并下腔静脉瘤栓的肾癌患者下腔静脉壁侵犯
BMC Med Imaging. 2024 Oct 31;24(1):295. doi: 10.1186/s12880-024-01466-3.
2
Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogeneity of PET-CT.胰腺癌中癌症相关成纤维细胞的代谢重编程促成了PET-CT的肿瘤内异质性。
Comput Struct Biotechnol J. 2023 Apr 7;21:2631-2639. doi: 10.1016/j.csbj.2023.04.003. eCollection 2023.
3
Prognostic Significance of F-FDG PET/CT Imaging in Survival Outcomes in Patients with Renal Cell Carcinoma.

本文引用的文献

1
Axitinib for preoperative downstaging of renal cell carcinoma with sarcomatoid differentiation and direct invasion of the duodenum and inferior vena cava: a case report.阿昔替尼治疗具有圆细胞分化且直接侵犯十二指肠和下腔静脉的肾细胞癌的术前降期:一例报告。
Onco Targets Ther. 2014 Feb 15;7:289-95. doi: 10.2147/OTT.S58089. eCollection 2014.
2
Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma.系统大中性氨基酸转运体(LAT)-1 mRNA表达增加与人类透明细胞肾细胞癌的侵袭潜能及不良预后相关。
BMC Cancer. 2013 Oct 30;13:509. doi: 10.1186/1471-2407-13-509.
3
F-FDG PET/CT成像在肾细胞癌患者生存结局中的预后意义
Mol Imaging Radionucl Ther. 2022 Oct 19;31(3):200-206. doi: 10.4274/mirt.galenos.2022.42744.
4
Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation.SDHB 基因突变所致嗜铬细胞瘤和副神经节瘤中 Nrf2 的表达增加和葡萄糖摄取增加。
BMC Cancer. 2022 Mar 18;22(1):289. doi: 10.1186/s12885-022-09415-5.
5
Role of F-18 FDG PET/CT in the follow-up of asymptomatic renal cell carcinoma patients for postoperative surveillance: based on conditional survival analysis.基于条件生存分析,F-18 FDG PET/CT 在无症状肾细胞癌患者术后随访中的作用:用于术后监测。
J Cancer Res Clin Oncol. 2022 Jan;148(1):215-224. doi: 10.1007/s00432-021-03688-2. Epub 2021 Jun 9.
6
Glycolysis on F-18 FDG PET/CT Is Superior to Amino Acid Metabolism on C-11 Methionine PET/CT in Identifying Advanced Renal Cell Carcinoma at Staging.在晚期肾细胞癌分期中,F-18 FDG PET/CT上的糖酵解在识别方面优于C-11蛋氨酸PET/CT上的氨基酸代谢。
Cancers (Basel). 2021 May 14;13(10):2381. doi: 10.3390/cancers13102381.
7
Fluorodeoxyglucose-positron emission tomography/computed tomography for differentiation of renal tumors in hereditary kidney cancer syndromes.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在遗传性肾癌综合征中用于区分肾脏肿瘤。
Abdom Radiol (NY). 2021 Jul;46(7):3301-3308. doi: 10.1007/s00261-021-02999-9. Epub 2021 Mar 10.
8
PGC1α downregulation and glycolytic phenotype in thyroid cancer.甲状腺癌中PGC1α的下调与糖酵解表型
J Cancer. 2019 Jun 9;10(16):3819-3829. doi: 10.7150/jca.30018. eCollection 2019.
9
Metastatic Tumor Burden and Loci as Predictors of First Line Sunitinib Treatment Efficacy in Patients with Renal Cell Carcinoma.转移性肿瘤负担和部位作为转移性肾细胞癌患者一线舒尼替尼治疗疗效的预测指标。
Sci Rep. 2019 May 23;9(1):7754. doi: 10.1038/s41598-019-44226-y.
10
FDG PET/CT as a survival prognostic factor in patients with advanced renal cell carcinoma.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描作为晚期肾细胞癌患者生存预后因素。
Clin Exp Med. 2019 Feb;19(1):143-148. doi: 10.1007/s10238-018-0539-9. Epub 2018 Nov 28.
Recent advances in the treatment of metastatic renal cell carcinoma.
转移性肾细胞癌治疗的最新进展。
Int J Urol. 2013 Oct;20(10):944-55. doi: 10.1111/iju.12187. Epub 2013 May 21.
4
Molecular pathways: Fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer.分子通路:琥珀酸脱氢酶缺陷型肾癌——针对癌症中的瓦博格效应。
Clin Cancer Res. 2013 Jul 1;19(13):3345-52. doi: 10.1158/1078-0432.CCR-13-0304. Epub 2013 Apr 30.
5
Identification of eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer by integrative genomic profiling.整合基因组分析鉴定宫颈癌中反复出现的 3p12-p14 缺失的 8 个候选靶基因。
J Pathol. 2013 May;230(1):59-69. doi: 10.1002/path.4168. Epub 2013 Mar 14.
6
Targeting PI3K and mTORC2 in metastatic renal cell carcinoma: new strategies for overcoming resistance to VEGFR and mTORC1 inhibitors.针对转移性肾细胞癌中的 PI3K 和 mTORC2:克服 VEGFR 和 mTORC1 抑制剂耐药的新策略。
Int J Cancer. 2013 Aug 15;133(4):788-96. doi: 10.1002/ijc.28023. Epub 2013 Feb 12.
7
Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course.采用 FDG-PET/CT 对晚期肾细胞癌患者进行早期评估,可预测酪氨酸激酶抑制剂治疗的疾病进程。
BMC Cancer. 2012 May 2;12:162. doi: 10.1186/1471-2407-12-162.
8
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.多区域测序揭示的肿瘤内异质性和分支进化。
N Engl J Med. 2012 Mar 8;366(10):883-892. doi: 10.1056/NEJMoa1113205.
9
Functional imaging: what evidence is there for its utility in clinical trials of targeted therapies?功能成像:在靶向治疗的临床试验中,它有哪些应用证据?
Br J Cancer. 2012 Feb 14;106(4):619-28. doi: 10.1038/bjc.2011.579. Epub 2012 Jan 26.
10
Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancer.连续 FDG-PET/CT 作为舒尼替尼治疗转移性透明细胞肾细胞癌反应的生物标志物。
Clin Cancer Res. 2011 Sep 15;17(18):6021-8. doi: 10.1158/1078-0432.CCR-10-3309. Epub 2011 Jul 8.